CAS: 1316059-00-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK 854 REF: 3D-BG165704CAS: 1316059-00-3 | Min. 95% | 310.00 €~1,971.00 € | Tue 21 Jan 25 |
 | GSK854 REF: TM-T24115CAS: 1316059-00-3 | 98.79% | 95.00 €~3,480.00 € | Tue 28 Jan 25 |
GSK 854
CAS:1316059-00-3
Molecular probe for understanding the biology of troponin I-interacting kinase (TNNI3K) and its role in …
Formula:
C18H19ClN6O4S2
Purity:
Min. 95%
Molecular weight:
482.97 g/mol
Ref: 3D-BG165704
| 1mg | 310.00 € | ||
| 2mg | 465.00 € | ||
| 5mg | 740.00 € | ||
| 10mg | 1,102.00 € | ||
| 25mg | 1,971.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GSK854
CAS:1316059-00-3
GSK854 is a selective TNNI3K inhibitor reducing heart damage and stress post-infarction in mice.
Formula:
C18H19ClN6O4S2
Purity:
98.79%
Color and Shape:
Solid
Molecular weight:
482.96
Ref: TM-T24115
| 1mg | 95.00 € | ||
| 5mg | 230.00 € | ||
| 10mg | 371.00 € | ||
| 25mg | 732.00 € | ||
| 50mg | 1,100.00 € | ||
| 100mg | 1,735.00 € | ||
| 500mg | 3,480.00 € | ||
| 1mL*10mM (DMSO) | 257.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
